EUVIMEDEUVIMED entdecken
Open Access

Haploinsufficiency of phosphodiesterase 10A activates PI3K/AKT signaling independent of PTEN to induce an aggressive glioma phenotype

Nicholas Nuechterlein, Allison Shelbourn, Frank Szulzewsky, Sonali Arora, Michelle Casad, Siobhan Pattwell, Leyre Merino-Galan, Erik Sulman iD, Sumaita Arowa, Neriah Alvinez, Miyeon Jung, Desmond Brown und 16 weitere

Genes & Development · 2024

DOI: 10.1101/gad.351350.123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes & Development, 2024. Verfasst von Nicholas Nuechterlein und 27 weiteren Autor:innen. Beteiligte Einrichtung: Neuropathology Unit, Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Mar…. Hauptthemen laut MEDLINE: Glioblastoma, Glioma, Brain Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NINDS NIH HHS, National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma is universally fatal and characterized by frequent chromosomal copy number alterations harboring oncogenes and tumor suppressors. In this study, we analyzed exome-wide human glioblastoma copy number data and found that cytoband 6q27 is an independent poor prognostic marker in multiple data sets. We then combined CRISPR–Cas9 data, human spatial transcriptomic data, and human and mouse RNA sequencing data to nominate PDE10A as a potential haploinsufficient tumor suppressor in the 6q27 region. Mouse glioblastoma modeling using the RCAS/tv-a system confirmed that Pde10a suppression induced an aggressive glioma phenotype in vivo and resistance to temozolomide and radiation therapy in vitro. Cell culture analysis showed that decreased Pde10a expression led to increased PI3K/AKT signaling in a Pten-independent manner, a response blocked by selective PI3K inhibitors. Single-nucleus RNA sequencing from our mouse gliomas in vivo, in combination with cell culture validation, further showed that Pde10a suppression was associated with a proneural-to-mesenchymal transition that exhibited increased cell adhesion and decreased cell migration. Our results indicate that glioblastoma patients harboring PDE10A loss have worse outcomes and potentially increased sensitivity to PI3K inhibition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaGliomaBrain NeoplasmsHumansAnimalsMicePhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktHaploinsufficiencyPTEN PhosphohydrolasePhosphoric Diester HydrolasesCell Line, Tumor

Stichwörter der Autor:innen

PDE10API3K/ATK pathwayRCAS/tv-aglioblastomamesenchymal cell state

Substanzen

Phosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktPTEN PhosphohydrolasePhosphoric Diester HydrolasesPTEN protein, humanPDE10A protein, human

Autor:innen und Institutionen

  • Neuropathology Unit, Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20814, USA.
  • Human Biology Division, Fred Hutchinson Cancer Center, Seattle, Washington 98109, USA.
  • Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington 98195, USA.
  • Ben Towne Center for Childhood Cancer Research, Seattle Children's Research Institute, Seattle, Washington 98145, USA.
  • Department of Radiation Oncology, New York University Grossman School of Medicine, New York, New York 11220, USA.
  • Neurosurgical Oncology Unit, Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20814, USA.

ORCID-Profile: Erik Sulman, Prashant Chittaboina, Zied Abdullaev, Patrick J Cimino

Förderung

  • NCI NIH HHS
  • NINDS NIH HHS
  • National Science Foundation
  • National Cancer Institute
  • National Institute of Neurological Disorders and Stroke
  • National Institutes of Health

Zitieren

APA

Nuechterlein, N., Shelbourn, A., Szulzewsky, F., Arora, S., Casad, M., Pattwell, S., Merino-Galan, L., Sulman, E., Arowa, S., Alvinez, N., Jung, M., Brown, D., Tang, K., Jackson, S., Stoica, S., Chittaboina, P., Banasavadi-Siddegowda, Y. K., Wirsching, H. G., Stella, N., …, & Cimino, P. J. (2024). Haploinsufficiency of phosphodiesterase 10A activates PI3K/AKT signaling independent of PTEN to induce an aggressive glioma phenotype. Genes & Development. https://doi.org/10.1101/gad.351350.123

Vancouver

Nuechterlein N, Shelbourn A, Szulzewsky F, Arora S, Casad M, Pattwell S, et al. Haploinsufficiency of phosphodiesterase 10A activates PI3K/AKT signaling independent of PTEN to induce an aggressive glioma phenotype. Genes & Development. 2024. doi:10.1101/gad.351350.123

BibTeX
@article{Nuechterlein2024,
  author = {Nuechterlein, Nicholas and Shelbourn, Allison and Szulzewsky, Frank and Arora, Sonali and Casad, Michelle and Pattwell, Siobhan and Merino-Galan, Leyre and Sulman, Erik and Arowa, Sumaita and Alvinez, Neriah and Jung, Miyeon and Brown, Desmond and Tang, Kayen and Jackson, Sadhana and Stoica, Stefan and Chittaboina, Prashant and Banasavadi-Siddegowda, Yeshavanth K and Wirsching, Hans-Georg and Stella, Nephi and Shapiro, Linda and Paddison, Patrick and Patel, Anoop P and Gilbert, Mark R and Abdullaev, Zied and Aldape, Kenneth and Pratt, Drew and Holland, Eric C and Cimino, Patrick J},
  title = {Haploinsufficiency of phosphodiesterase 10A activates PI3K/AKT signaling independent of PTEN to induce an aggressive glioma phenotype},
  journal = {Genes & Development},
  year = {2024},
  doi = {10.1101/gad.351350.123}
}
Kostenlos starten →